A carregar...
Study design considerations for the Standardized Treatment Of Pulmonary exacerbations 2 (STOP2): a trial to compare intravenous antibiotic treatment durations in CF
BACKGROUND: Pulmonary exacerbations (PEx) in cystic fibrosis (CF) are common and contribute to morbidity and mortality. Duration of IV antibiotic therapy to treat PEx varies widely in the US, and there are few data to guide treatment decisions. METHODS: We combined a survey of CF stakeholders with r...
Na minha lista:
| Publicado no: | Contemp Clin Trials |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5742044/ https://ncbi.nlm.nih.gov/pubmed/29170074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2017.11.012 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|